Hey everyone! I hope everyone has had a great October. Here are some TBRS Community updates and reminders for this week:
Updates on Variants of Uncertain Significance (VUS)
Recently, scientists have made headway in understanding some gene variants involved in TBRS, especially those called variants of uncertain significance (VUS).
VUS means that clinicians aren’t sure if genetic changes they find could cause health issues related to TBRS or not.
Thanks to new research, we’re seeing a clearer picture because of a change in what’s called a haploinsufficiency score
A haploinsufficiency score tells us how sensitive a gene is when one of its two copies doesn’t work properly.
If a gene has a high haploinsufficiency score, it means losing function in one copy can cause health issues, while a low score might mean it doesn't affect health as much.
With recent research, the haploinsufficiency score for DNMT3A –the gene that causes TBRS – has changed (and is now higher), which means some VUS could now be reclassified as pathogenic or likely pathogenic. In other words, this helps clarify diagnosis.
For patients, this could have real benefits, like helping with insurance coverage or even shaping their treatment plans.
This research is a huge step forward in understanding TBRS and helping affected families receive clearer answers and support!
My TBRS lecture at the University of Pittsburgh
This week, I had the honor of speaking to a group of public health master’s students at the University of Pittsburgh, where I completed my Masters.
My lecture covered:
What it’s like to work with the TBRS Community
The impact of rare disease advocacy
Ways students can get involved in this field
I’m hopeful this visit will help bring more interns our way and raise awareness of TBRS, as we strive to inspire the next generation of advocates and researchers in rare disease!